RosVivo Therapeutics stands out due to the fact that the miRNA medications we are creating are aimed at reversing various metabolic conditions rather than simply alleviating symptoms. These conditions can be rectified at a molecular level by replenishing the diminished miRNAs responsible for triggering these illnesses. RosVivo is leveraging distinctive scientific insights to pioneer a novel portfolio of groundbreaking medications and diagnostic examinations. Our research and development initiatives are centered on pioneering T2D, obesity, and COVID-19 pharmaceutical candidates.
Rosvivo Therapeutics
Headquarters
United States of America